ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.

March 2, 2001

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

March 8, 1991

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Clinical Trials Approved By NCI

November 26, 2010

Nixon to Receive ACCC Annual Award

January 10, 1986